Table 1 Age standardised incidence rates of oropharyngeal and oral cavity cancers in Australiaa

From: Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers

 

Potentially HPV-associated cancers

 

Tonsil b

Base of tongue and lingual tonsil c

Other oropharynx d

Comparison cancers e

Time

Count (%)

Rate f

95% CI

Count (%)

Rate

95% CI

Count (%)

Rate

95% CI

Count (%)

Rate

95% CI

1982–2005

 Total

3898 (100)

0.98

0.95–1.01

2610 (100)

0.66

0.63–0.68

2336 (100)

0.58

0.56–0.61

28 379 (100)

7.12

7.04–7.21

 Females

925 (23.7)

0.45

0.42–0.48

623 (23.9)

0.30

0.27–0.32

493 (21.1)

0.23

0.21–0.25

6591 (23.2)

3.11

3.03–3.18

 Males

2973 (76.3)

1.54

1.49–1.60

1987 (76.1)

1.04

0.99–1.08

1843 (78.9)

0.97

0.92–1.01

21 788 (76.8)

11.58

11.42–11.73

2000–2005

 Total

1315 (100)

1.09

1.03–1.15

954 (100)

0.79

0.74–0.84

661 (100)

0.55

0.50–0.59

7453 (100)

6.17

6.03–6.31

 Females

282 (21.4)

0.46

0.40–0.51

227 (23.8)

0.36

0.31–0.41

128 (19.3)

0.20

0.16–0.23

1866 (25.0)

2.89

2.76–3.03

 Males

1033 (78.6)

1.74

1.64–1.85

727 (76.2)

1.23

1.14–1.32

533 (80.6)

0.91

0.84–0.99

5587 (75.0)

9.75

9.5–10.01

1994–1999

 Total

993 (100)

0.95

0.89–1.01

786 (100)

0.75

0.70–0.80

650 (100)

0.62

0.57–0.67

7296 (100)

6.99

6.83–7.15

 Females

236 (23.8)

0.44

0.38–0.49

190 (24.2)

0.35

0.30–0.39

149 (22.9)

0.27

0.22–0.31

1803 (24.7)

3.23

3.08–3.38

 Males

757 (76.2)

1.50

1.39–1.61

596 (75.8)

1.19

1.09–1.28

501 (77.1)

1.02

0.93–1.11

5493 (75.3)

11.16

10.86–11.45

1988–1993

 Total

833 (100)

0.90

0.84–0.97

518 (100)

0.57

0.52–0.62

558 (100)

0.60

0.55–0.65

7114 (100)

7.70

7.52–7.88

 Females

202 (24.3)

0.42

0.36–0.48

128 (24.7)

0.26

0.22–0.31

122 (21.9)

0.24

0.20–0.29

1559 (21.9)

3.18

3.02–3.33

 Males

631 (75.7)

1.42

1.31–1.54

390 (75.3)

0.90

0.80–0.99

436 (78.1)

0.98

0.88–1.07

5555 (78.1)

12.72

12.37–13.06

1982–1987

 Total

757 (100)

0.92

0.85–0.98

352 (100)

0.43

0.39–0.48

467 (100)

0.57

0.52–0.62

6516 (100)

8.02

7.82–8.22

 Females

205 (27.1)

0.48

0.41–0.55

78 (22.2)

0.18

0.14–0.22

94 (20.1)

0.22

0.17–0.26

1363 (20.9)

3.17

3.00–3.34

 Males

552 (72.9)

1.41

1.29–1.53

274 (77.8)

0.71

0.62–0.79

373 (79.9)

0.97

0.86–1.07

5153 (79.1)

13.50

13.11–13.86

  1. Abbreviations: CI=confidence interval; HPV=human papillomavirus.
  2. aSquamous cell carcinomas.
  3. bTonsil (including Waldeyer's ring) – C09.0, C09.1, C09.8, C09.9 and C14.2.
  4. cBase of tongue and lingual tonsil – C01.9 and C02.4.
  5. dOther oropharynx – C02.8, C10.2, C10.8, C10.9, C14.0 and C14.8.
  6. eComparison cancers (Ryerson et al, 2008) –
  7. (a) Oral tongue – C02.0, C02.1, C02.2, C02.3 and C02.9.
  8. (b) Other oral cavity sites – C03.0, C03.1, C03.9, C04.0, C04.1, C04.8, C04.9, C05.0, C06.0, C06.1, C06.2, C06.8 and C06.9.
  9. (c) Larynx – C32.0, C32.1, C32.2, C32.3, C32.8 and C32.9.
  10. (d) Other oropharynx sites – C05.1, C05.2, C05.8, C05.9, C10.0, C10.1 and C10.3.
  11. fRates are per 100 000 population and are age standardised to the 2001 Australian population (5 year age groups). (Australian Bureau of Statistics, 2008.)
Back to article page